SARC

Our goal is to achieve breakthroughs in sarcoma research that help improve patient outcomes, and ultimately lead to a cure.

Find a SARC Study

View SARC clinical trials

Resources for Researchers

Biospecimens, Clinical Data

SARC Scientific Committees

Meet our experts

SARC FUNDING

LEARN HOW TO APPLY

Tseng 2015

WILLIAM W. TSENG, MD
University of Southern California
Immune Profiling in Well Differentiated/Dedifferentiated Liposarcoma

Read more about Tseng 2015
Log in to post comments

Lilly Reports Results of Phase 3 Soft Tissue Sarcoma

Today, Eli Lilly reported that the results of their Phase 3 study of olaratumab (LARTRUVO®) in combination with doxorubicin versus doxorubicin alone in patients with advanced or metastatic soft tissue sarcoma showed no difference in survival between the study arms.

MEET THE PEOPLE OF SARC

Denise Reinke, President and CEO of SARC

Denise Reinke has been with SARC since its inception in 2002 assuming increasing responsibilities over the years. She is uniquely positioned to lead SARC as President and CEO given her sarcoma nurse practitioner, clinical trials, pharmaceutical and business experience.

Read full bio

See all bios

SARC - Sarcoma Alliance for Research Through Collaboration, Ann Arbor

Tseng 2015

Pages

Where can I find a sarcoma specialist?

Financial Contributions

Lilly Reports Results of Phase 3 Soft Tissue Sarcoma

MEET THE PEOPLE OF SARC